RSNA: Levothyroxine Tied to Bone Loss Over Time in Older Adults
By Lori Solomon HealthDay Reporter
MONDAY, Nov. 25, 2024 -- Levothyroxine (LT4) use is associated with longitudinal loss of bone mass and density in older adults, according to a study scheduled to be presented at the annual meeting of the Radiological Society of North America, held from Dec. 1 to 5 in Chicago.
Elena Ghotbi, M.D., from the Johns Hopkins University School of Medicine in Baltimore, and colleagues examined whether LT4 use and higher thyroid hormone levels within the reference range are associated with greater bone loss over time in older adults. The analysis included data from participants (aged 65 years and older) in the Baltimore Longitudinal Study of Aging (81 LT4 users and 364 propensity-matched nonusers).
The researchers found that during a median follow-up of 6.3 years, LT4 use was associated with greater longitudinal loss of total body bone mass (beta, −6.53) and total body bone density (beta, −0.0014). With an increasing tertile of average free thyroxine, the association was stronger.
"Longitudinal loss of bone mass and density was greater among euthyroid LT4 users," the authors write. "The more pronounced effects at higher levels of free thyroxine suggest that LT4 use may be associated with a relative excess of thyroid hormone in some older adults on therapy, even with thyroid-stimulating hormone levels within the reference range."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted November 2024
Read this next
Thresholds for Preop Serum Calcitonin Predict Lymph Node Metastasis in Thyroid Cancer
WEDNESDAY, July 2, 2025 -- Updated threshold values of preoperative serum calcitonin predict different extents of lymph node metastasis (LNM) in patients with medullary thyroid...
Weighted Vests Do Not Prevent Weight Loss-Linked Bone Loss at Hip
TUESDAY, July 1, 2025 -- For older adults with obesity, neither weighted vest use nor resistance training (RT) mitigates weight loss (WL)-associated bone loss at the hip...
Topical Testosterone + Exercise No Aid for Hip Fracture Recovery in Women
TUESDAY, May 20, 2025 -- Topical testosterone therapy does not significantly improve functional outcomes beyond supervised exercise training in older women recovering from a hip...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.